What is the strongest weight loss prescription pill?

Choosing a weight loss prescription pill is a significant medical decision. This article explains what prescription options exist, how they work, and which medication currently delivers the greatest average weight loss in clinical trials. You will learn the benefits and risks of clinically approved weight pills, how they compare, and why medical oversight matters. We also outline how nutritional supplements can support broader health during medical weight management. If you’re researching the strongest weight loss prescription pill, this guide clarifies the science, highlights individual variability, and helps you understand when supplements may provide value alongside a physician-guided plan.

Introduction

Weight management is rarely simple. Biology, lifestyle, and health conditions interact in complex ways that can make meaningful, safe weight loss challenging. In recent years, prescription slimming medications—often called “clinically approved weight pills,” “fat burner medications,” or “prescription fat loss drugs”—have evolved dramatically, offering new, evidence-based tools for people who meet medical criteria. Yet the most effective option for one person may not be best for another. This article provides a clear, medically responsible overview of prescription options, shows how they work in the body, and examines when nutritional supplements may contribute to a comprehensive, doctor-supervised plan.

Core Explanation of the Topic

What Is a Weight Loss Prescription Pill?

A weight loss prescription pill is a medication authorized by a regulatory agency (such as the FDA in the United States or EMA in Europe) for chronic weight management in people who meet specific criteria (typically adults with a body mass index [BMI] ≥30 kg/m², or ≥27 kg/m² with weight-related conditions like type 2 diabetes, hypertension, or dyslipidemia). These are not over-the-counter products. They undergo rigorous clinical testing for safety and efficacy and require ongoing medical oversight.

In contrast, over-the-counter supplements do not treat obesity and are not evaluated to the same standard as prescription medications. Prescription options can include daily pills, extended-release capsules, or injectables, each with distinct mechanisms. Examples of clinically approved weight pills and injectables include orlistat, phentermine/topiramate, naltrexone/bupropion, liraglutide, semaglutide, and tirzepatide (some are injections rather than “pills,” but are often grouped with prescription weight-loss medications). Additionally, short-term appetite suppressants (e.g., phentermine alone) may be used under strict supervision, and certain rare genetic forms of obesity may be treated with specific agents like setmelanotide.

How Do Prescription Fat Loss Drugs Work?

Prescription weight-loss medications act through several biological pathways:

• Appetite suppression: Some medications target central nervous system pathways (e.g., hypothalamic circuits that regulate hunger and satiety) to reduce appetite and food intake. Sympathomimetic agents (like phentermine) and combinations (such as naltrexone/bupropion) can modulate neurotransmitters (norepinephrine, dopamine, POMC neurons) involved in hunger, cravings, and reward.
• Fat absorption reduction: Orlistat inhibits gastrointestinal lipases, decreasing dietary fat breakdown and absorption. The unabsorbed fat is excreted, modestly lowering calorie intake but also requiring attention to fat-soluble vitamin status.
• Metabolic rate and energy balance: Some drugs indirectly influence resting energy expenditure or facilitate negative energy balance by reducing intake and improving adherence to a calorie deficit.
• Neurospecific target mechanisms: GLP-1 receptor agonists (liraglutide, semaglutide) and dual agonists acting on GLP-1 and GIP receptors (tirzepatide) regulate appetite centers and slow gastric emptying, helping people feel fuller with less food and altering reward-based eating. These neurometabolic effects are potent and have transformed modern medical weight management.

Which Prescription Option Is “Strongest” Right Now?

“Strongest” typically refers to average weight reduction demonstrated in high-quality clinical trials. Based on current evidence, tirzepatide (approved for chronic weight management in many regions under brand names such as Zepbound) has shown the largest average weight loss among widely available, clinically approved prescription options. Across 72-week studies, many participants experienced total body weight reductions in the range of 15–22% with tirzepatide when combined with lifestyle changes, though individual results vary.

Close behind is semaglutide 2.4 mg weekly (Wegovy), which has shown average weight loss of roughly 10–15% over 68 weeks in clinical trials when combined with behavioral support. Other long-term options include phentermine/topiramate extended-release (often yielding 8–10% on average), liraglutide 3.0 mg (~5–8%), naltrexone/bupropion (~4–6%), and orlistat (~3–5%).

However, “strongest” is not automatically “best.” Suitability depends on your medical history, tolerability, medication interactions, costs and coverage, reproductive plans, and personal preferences. Some individuals do better with one agent than another, and managing side effects—particularly gastrointestinal effects with gut-hormone–based therapies—can shape the choice. The optimal prescription therapy is the one that is effective, safe, and sustainable for you under your clinician’s guidance.

Why This Topic Matters

Obesity and overweight are linked to cardiometabolic conditions such as hypertension, type 2 diabetes, fatty liver disease, dyslipidemia, sleep apnea, osteoarthritis, and depression. Even a 5–10% reduction in body weight can improve markers like blood pressure, glucose control, and lipid profiles for many people. As a result, evidence-based, long-term strategies carry real health value. But the marketplace is crowded with over-the-counter fat burner medications and bold claims. Understanding how clinically approved weight pills differ—and when and how to combine them with nutritional supplements—can help you make safer, more effective choices grounded in science instead of hype.

Related Symptoms, Signals, or Health Implications

Recognizing When Weight Loss Is a Medical Concern

Medical weight management may be appropriate when excess adiposity is persistent, progressive, or associated with complications. Clues include steady weight gain despite structured diet and activity, significant difficulty sustaining weight loss over time, and coexisting conditions such as type 2 diabetes, prediabetes, hypertension, polycystic ovary syndrome (PCOS), or sleep apnea. If BMI meets medical criteria for treatment—or if central adiposity is high relative to BMI—clinical evaluation can help identify safer, more personalized options than trial-and-error approaches.

Symptoms and Signals That Warrant Medical Attention

• Persistent fatigue, daytime sleepiness, or disrupted sleep patterns
• Strong cravings, dysregulated appetite, or binge-eating tendencies
• Unexplained changes in body composition (e.g., increasing waist circumference)
• Plateaus or regains despite consistent diet and exercise
• Side effects or over-restriction from self-directed dieting attempts
• Emerging comorbidities such as elevated blood pressure, fasting glucose, or triglycerides

These signs do not diagnose a cause but do indicate that a clinical assessment—including medication options and adjunctive support—may be beneficial.

Health Implications of Untreated or Mismanaged Weight Issues

When excess adiposity is not addressed, the risk of cardiovascular disease, insulin resistance, and fatty liver disease tends to rise. Biomechanical strain on joints can worsen pain and mobility limitations, potentially reducing physical activity and creating a cycle that sustains weight gain. Psychosocial effects—including stigma, reduced quality of life, and mood disorders—can also amplify barriers to change. Responsible, evidence-based care aims to break this cycle by safely reducing weight, preserving lean mass, and supporting long-term health.

Why Symptoms Alone Do Not Reveal the Root Cause

Symptoms such as hunger, fatigue, or plateaus are nonspecific. They can result from multiple factors—sleep disruption, chronic stress, medications (e.g., certain antidepressants or antipsychotics), endocrine conditions (e.g., hypothyroidism, Cushing’s syndrome), or genetics (including appetite regulation variants). Without evaluation, it’s difficult to know which pathway is most responsible. For example, intense cravings might reflect reward-circuit dysregulation, irregular meal timing, or side effects of a medication you take for another condition.

This is why guessing often backfires. Selecting a weight loss prescription pill based solely on “feeling hungrier” or “feeling tired” can miss the bigger picture. A medical workup can clarify potential contributors—metabolic markers, sleep health, mental health, medication effects—and guide a safer, more precise plan. It can also identify situations in which non-pharmacologic strategies, a different medication class, or temporary deferral of therapy is more appropriate.

The Role of Nutritional Supplements in Weight Management

Understanding Nutritional Supplements

Nutritional supplements are not prescription fat loss drugs. They include vitamins, minerals, fibers, essential fatty acids, and botanicals that may support overall health. Some can indirectly assist with weight management behaviors—by promoting satiety (e.g., viscous fibers), supporting energy metabolism, or aiding sleep and stress resilience—without treating obesity itself. Quality matters: reputable manufacturing standards, transparent labeling, and third-party testing help ensure you’re getting what the label states.

The Evidence for Supplements Supporting Weight Loss

• Fiber (e.g., glucomannan, psyllium, inulin): Viscous fibers can promote fullness, modestly reduce calorie intake, and support glycemic control, especially when combined with higher-protein meals and hydration.
• Protein supplementation: Adequate protein supports lean mass during a calorie deficit. Whey, casein, or plant-based proteins can help reach targets, especially if appetite is suppressed by medications and total food intake falls.
• Green tea extract/catechins with caffeine: May modestly increase thermogenesis and fat oxidation. Effects are small and vary widely; safety hinges on dose and product quality.
• Omega-3 fatty acids (EPA/DHA): Not a weight-loss agent, but supportive for cardiometabolic health, triglycerides, and inflammation pathways—useful adjuncts during weight reduction. See options in the omega‑3 (EPA/DHA) collection.
• Micronutrients (vitamin D, magnesium, etc.): Deficiencies can affect energy, mood, muscle function, and sleep. Optimizing status can support adherence to lifestyle changes. Explore vitamin D resources and magnesium options to support bone, muscle, and sleep health during weight loss.
• Probiotics/prebiotics: Early research suggests the gut microbiome may influence weight-regulation pathways. While findings are mixed, some strains may aid metabolic parameters.

Importantly, supplements are not substitutes for clinically approved weight pills when medical therapy is indicated. Their role is supportive—helping cover nutritional gaps, comfort, or adherence within a broader plan.

When and Why Nutritional Supplements Make Sense

Supplements can be helpful if your diet is calorie-restricted, if orlistat reduces absorption of fat-soluble vitamins, or if appetite-suppressing therapies reduce your intake of nutrient-dense foods. They can also assist with common barriers: adequate protein for satiety and muscle maintenance, fiber for digestive comfort and fullness, and micronutrients for sleep quality and energy metabolism. In some contexts, clinicians recommend multivitamins or targeted nutrients during medical weight management, particularly if lab tests reveal deficiencies. The goal is not to claim that supplements cause weight loss, but to support the physiology and behaviors that enable safe, sustainable progress.

Overview of Major Prescription Options: Benefits and Considerations

Below is a high-level summary of commonly used, clinically approved weight-management medications. Suitability requires clinician oversight.

• Tirzepatide (GLP‑1/GIP receptor agonist): Among the highest average weight reductions in clinical trials. Common side effects include gastrointestinal symptoms (nausea, vomiting, diarrhea, constipation) that often improve with slow dose titration. Potential risks include gallbladder issues; not recommended for certain rare endocrine tumor histories. Requires adherence to dosing schedule and ongoing lifestyle measures.
• Semaglutide 2.4 mg weekly (GLP‑1 receptor agonist): Robust average weight loss with appetite regulation and slowed gastric emptying. Similar GI side effects and precautions as tirzepatide. Often works well with structured nutrition and resistance training to preserve lean mass.
• Liraglutide 3.0 mg daily (GLP‑1 receptor agonist): Daily injection with meaningful but somewhat lower average weight loss than semaglutide/tirzepatide. GI tolerability and gradual titration remain important. Approved for adolescents in some regions.
• Phentermine/topiramate extended-release: Oral combination with appetite-suppressing and satiety-enhancing effects. Considerations include paresthesias, dry mouth, insomnia, mood changes, and potential teratogenicity (strict pregnancy prevention required). Heart rate and mental health monitoring may be advised.
• Naltrexone/bupropion: Targets reward pathways and appetite regulation (POMC neurons), potentially useful for cravings and emotional eating patterns. May raise blood pressure or heart rate; bupropion lowers seizure threshold and interacts with certain medications. Careful screening is essential.
• Orlistat: Inhibits fat absorption. Gastrointestinal side effects (oily stools, urgency) are common without dietary fat modification. May reduce absorption of fat-soluble vitamins (A, D, E, K); spacing a multivitamin or targeted micronutrients from orlistat dosing is often recommended. Consider monitoring vitamin D and K status and support bone health; resources on vitamin K and vitamin D may be useful.
• Short-term sympathomimetic agents (e.g., phentermine alone): May be prescribed briefly for appetite suppression. Require caution with cardiovascular risk, insomnia, anxiety, and dependency potential. Long-term efficacy is generally inferior without a comprehensive plan.
• Special indications (e.g., setmelanotide): For rare genetic forms of obesity (e.g., POMC/LEPR deficiency). Requires genetic confirmation and specialist oversight.

Across medications, lifestyle strategies—adequate protein intake, resistance training, sleep optimization, and stress management—help preserve lean mass, improve metabolic health markers, and enhance long-term maintenance.

Practical Mechanisms: How These Drugs Change Biology and Behavior

Appetite is regulated by an interplay of signals: gut hormones (GLP‑1, GIP, PYY), adipokines (leptin), nutrients, sensory cues, and central circuits in the hypothalamus and mesolimbic reward system. GLP‑1–based therapies reduce hunger, slow stomach emptying (prolonging fullness), and dampen reward-driven eating. Naltrexone/bupropion modulates POMC neurons and dopaminergic pathways to reduce cravings. Phentermine increases norepinephrine to suppress appetite, while topiramate likely acts via GABAergic and glutamatergic signaling to promote satiety. Orlistat works peripherally, preventing fat breakdown in the gut; there are no central appetite effects, so dietary changes remain crucial.

None of these mechanisms bypass the need for a caloric deficit, but they can make it more achievable and sustainable. By reducing hunger or cravings, or by making fat intake less rewarding, these medications help individuals adhere to personalized nutrition and activity plans over months to years.

Why This Topic Matters for Health and Safety

Medications with the greatest average effect can have distinct side-effect profiles and contraindications. For example, teratogenic risks with topiramate require strict pregnancy prevention; bupropion may not suit people with seizure risk; GLP‑1–based therapies require caution in people with certain endocrine tumor histories and may raise gallbladder risk. Because these details directly influence safety, it’s unwise to select a prescription solely based on expected weight loss. The best outcomes arise when a clinician matches mechanism to your biology, comorbidities, and preferences, while monitoring labs, side effects, and progress.

Decision Factors Beyond “Strength”

• Medical eligibility: BMI thresholds and presence of comorbidities determine candidacy.
• Side-effect tolerance: GI sensitivity, sleep, and mood history matter.
• Medication interactions: Blood pressure control, seizure risk, and psychiatric history can influence choices.
• Reproductive plans: Teratogenicity risks (e.g., topiramate) and preconception planning should be addressed.
• Administration preferences: Willingness to use weekly or daily injections versus oral agents.
• Cost and coverage: Access and affordability shape long-term adherence.
• Lifestyle alignment: Nutrition, exercise, sleep, and stress strategies to synergize with the chosen medication.

Related Symptoms, Signals, or Health Implications

When Weight Changes Signal Underlying Conditions

Unexplained weight gain, escalating appetite, or refractory plateaus can reflect endocrine imbalances (e.g., hypothyroidism), medication side effects (e.g., certain mood stabilizers), chronic sleep disruption, or mood disorders that drive emotional eating. Screening labs and a medical review can identify correctable factors, guide medication choice, and tailor non-pharmacologic supports such as sleep or psychotherapy interventions.

Consequences of Under-Addressed Weight Challenges

Over time, untreated excess adiposity can worsen cardiovascular and metabolic risk. Joint stress may increase pain, discouraging physical activity and undermining weight loss attempts. Psychological impacts can drive cycles of restrictive dieting and rebound overeating. Intervention that integrates behavior change with appropriately chosen medication can break this pattern and improve health trajectories.

Why Symptoms Alone Do Not Reveal the Root Cause

Because multiple pathways influence appetite and weight, symptoms overlap. For example, both sleep deprivation and certain antidepressants can cause hunger and weight gain—but the best solution differs. Self-treating with over-the-counter fat burner medications or picking a prescription based on anecdote can delay accurate diagnosis and safer options. Medical evaluation adds clarity, such as identifying insulin resistance, medication-induced weight gain, or sleep apnea—each requiring different strategies.

How Supplements Can Add Value in a Medical Weight Management Plan

Supplements can support comfort, adherence, and overall health while you and your clinician implement a prescription plan. Examples include:

• Digestive comfort and satiety: Soluble fiber supplements may reduce hunger and improve regularity, especially if GLP‑1–based therapy slows gastric emptying.
• Protein sufficiency: Protein powders or ready-to-mix options can help you meet protein targets for muscle maintenance if appetite is reduced.
• Micronutrient sufficiency: Calorie restriction and food selectivity (due to nausea or early satiety) can reduce micronutrient intake. Vitamin D and magnesium are common shortfalls that affect bone, muscle, mood, and sleep. Explore vitamin D and magnesium options to support these domains.
• Cardiometabolic support: Omega‑3 (EPA/DHA) can complement dietary changes for triglyceride and inflammation pathways; see the EPA/DHA collection.

These supports do not replace medication or lifestyle changes, but they can make the process more sustainable and help you meet nutritional needs while pursuing clinically guided weight reduction.

Who Should Consider Nutritional Supplements

• Individuals with mild to moderate weight goals who want to improve diet quality and satiety
• People on prescription slimming medications who eat less and may need help meeting protein or micronutrient targets
• Those with documented deficiencies (e.g., low vitamin D) that may affect energy, bone health, or sleep
• Anyone implementing calorie restriction who wants to support digestive comfort, muscle maintenance, and overall well-being
• Patients using orlistat, who may need attention to fat-soluble vitamin status (timing supplements separately from doses)

Decision-Support: When Do Nutritional Supplements Make Sense?

Indicators That Nutritional Supplements Are Appropriate

• You are not hitting protein or fiber goals through food alone
• You experience low energy, sleep difficulties, or muscle cramps and lab work suggests micronutrient gaps
• Your clinician recommends supportive omega‑3s, vitamin D, or magnesium to complement diet and exercise
• You seek a holistic approach—combining medication, tailored nutrition, movement, sleep, and targeted supplements

Situations Warranting Professional Consultation

• Complex medical conditions (e.g., renal disease, hepatic concerns, malabsorption) that affect supplement choice or dosing
• Potential interactions with prescription weight loss drugs or other medications
• History of bariatric surgery or gastrointestinal disorders requiring individualized supplementation plans
• Pregnancy, breastfeeding, or plans to conceive—medication and supplement strategies may change substantially

Connecting the Dots: Prescription Pills and Nutritional Supplements Together

Prescription fat loss drugs can meaningfully reduce hunger and improve adherence, while supplements can fill nutritional gaps, support muscle, and maintain general well-being. Together with structured nutrition, resistance training, adequate sleep, and behavioral strategies, they form a comprehensive approach. Medical oversight ties these elements together: adjusting medication doses, tracking side effects, monitoring labs, and refining diet and supplement choices over time. This integrated care respects individual biology, avoids one-size-fits-all thinking, and aims for health improvements that last.

Safety, Monitoring, and Expectations

Regardless of the medication chosen, regular follow-up is essential. Many clinicians reassess at 12–16 weeks to confirm that benefits outweigh risks and that weight loss is on track (e.g., ≥5% reduction by 3–4 months for many therapies). They also monitor blood pressure, heart rate, lab markers, and tolerability. Dose titration for GLP‑1–based therapies is gradual to limit GI symptoms. If a medication is ineffective or poorly tolerated, alternatives or adjuncts may be considered. Long-term maintenance often includes continued medication use, progressive resistance training, and ongoing attention to dietary quality, sleep, and stress.

Comparing “Strongest” Options: Practical Considerations

• Magnitude of effect: Tirzepatide has the highest average weight loss reported in large trials to date; semaglutide is a close second. Both require injections and careful titration.
• Side-effect profile: GI effects are common initially with GLP‑1–based therapies; most people acclimate over weeks. Orlistat’s GI effects are dietary-fat dependent. Stimulant-like effects can occur with phentermine-containing regimens.
• Comorbidities: For people with type 2 diabetes, GLP‑1–based therapies can improve glycemic control; for those with depression or cravings, naltrexone/bupropion might be attractive if appropriate. Hypertension, seizure history, or gallbladder disease may influence choices.
• Lifestyle fit: If weekly injections or GI side effects are unacceptable, oral regimens might fit better—even at the cost of lower average weight loss.
• Cost and access: Insurance coverage and availability vary widely. Discuss affordability and long-term plans with your clinician.

Key Takeaways

• The “strongest” weight loss prescription option by average clinical-trial results is currently tirzepatide, with semaglutide close behind.
• Effectiveness must be weighed against side effects, medical history, cost, and personal preferences.
• Medications work best alongside nutrition, resistance training, sleep, and behavioral support.
• Symptoms alone rarely reveal root causes; medical evaluation identifies the best pathway for you.
• Supplements do not replace prescription therapy but can support satiety, muscle, sleep, and nutrient sufficiency.
• Fiber, adequate protein, omega‑3s, vitamin D, and magnesium are common supportive tools when appropriate.
• Orlistat users should pay attention to fat-soluble vitamin status (A, D, E, K) and timing of supplements.
• Regular follow-up, dose titration, and monitoring increase safety and long-term success.

Q&A: Strongest Prescription Options and Smart Supplement Use

Q1: What is the strongest weight loss prescription pill right now?
A1: Based on current evidence, tirzepatide shows the highest average weight loss in large clinical trials, with semaglutide close behind. “Strongest” does not mean best for everyone—suitability depends on your health profile, side-effect tolerance, and access.

Q2: How do GLP‑1 and GIP–GLP‑1 medications cause weight loss?
A2: They act on gut–brain pathways that regulate appetite and satiety, and they slow gastric emptying so you feel fuller on less food. They also influence reward-related eating, making it easier to adhere to a calorie deficit.

Q3: Are there effective oral options if I prefer not to take injections?
A3: Yes. Phentermine/topiramate and naltrexone/bupropion are oral options with proven though generally smaller average weight loss compared with leading injectables. Orlistat is another oral option that reduces fat absorption but requires dietary adjustments for tolerability.

Q4: Who qualifies for prescription weight management medications?
A4: Most approvals are for adults with BMI ≥30, or ≥27 with weight-related conditions such as hypertension, type 2 diabetes, or dyslipidemia. Pediatric indications exist for some agents; eligibility and safety should be reviewed with a clinician.

Q5: How long do I need to stay on these medications?
A5: Obesity is a chronic condition; many people benefit from long-term therapy. If treatment stops, appetite signals typically return and weight regain is common without sustained lifestyle strategies.

Q6: What side effects are most common with the “strongest” options?
A6: GLP‑1–based therapies often cause temporary gastrointestinal symptoms like nausea, vomiting, and diarrhea, especially during dose escalation. Slow titration and small, protein-forward meals can improve tolerability.

Q7: Will supplements help me lose more weight?
A7: Supplements are not weight-loss drugs, but they can support the process by improving satiety (fiber), muscle preservation (protein), sleep and stress resilience (e.g., magnesium when appropriate), and cardiometabolic health (omega‑3s). Their role is supportive rather than primary.

Q8: Can I take supplements with prescription slimming medications?
A8: Often yes, but check for interactions and timing. For example, if taking orlistat, separate fat-soluble vitamins from doses, and discuss any new supplement with your clinician.

Q9: How do I choose between tirzepatide and semaglutide?
A9: Consider average efficacy, side-effect tolerance, access and cost, and personal preference for dosing schedules. Your clinician can weigh medical history (e.g., gallbladder risk, pancreatitis history) and help you decide.

Q10: Is rapid weight loss better?
A10: Not necessarily. Sustainable, health-focused loss that preserves lean mass and fits your life is typically the goal. Extremely rapid loss can raise risks like gallstones and muscle loss if protein and resistance training are inadequate.

Q11: What lifestyle elements matter most while on medication?
A11: Adequate protein, resistance training, fiber-rich whole foods, hydration, consistent sleep, and stress management often determine long-term success. These factors help maintain muscle and support metabolic health.

Q12: Do vitamins like vitamin D or magnesium make a difference?
A12: If you’re deficient, optimizing levels can support bone, muscle, sleep, and mood—factors that influence adherence and well-being during weight loss. Consider discussing vitamin D and magnesium with your clinician based on labs and diet.

Conclusion

The strongest weight loss prescription pill by current averages is tirzepatide, with semaglutide a close second—yet the best choice is the one that fits your medical history, tolerability, and long-term plan. Medication works best when paired with high-quality nutrition, resistance training, sleep, and behavior support. Symptoms alone rarely pinpoint root causes; a medical evaluation clarifies pathways and safeguards your health. Nutritional supplements are not treatments for obesity, but they can be valuable allies—supporting nutrient sufficiency, satiety, muscle preservation, and overall well-being—within a comprehensive, clinician-guided strategy for sustainable weight management.

Keywords

weight loss prescription pill, prescription fat loss drugs, clinically approved weight pills, prescription slimming medications, fat burner medications, medical weight management, tirzepatide, semaglutide, liraglutide, phentermine/topiramate, naltrexone/bupropion, orlistat, GLP‑1, GIP, appetite suppression, fat absorption, satiety, fiber supplements, protein intake, omega‑3 EPA DHA, vitamin D, magnesium, personalized weight management